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Adeno-associated virus (AAV) is a human parvovirus that normally requires a helper virus such as adenovirus (Ad) for replication. The four
replication proteins (Rep78, 68, 52 and 40) encoded by AAV are pleiotropic effectors of virus integration, replication, transcription and virion
assembly. Using Rep68 column chromatography and mass spectrometry, we have identified the nucleolar, B23/Nucleophosmin (NPM) protein as
an Rep-interacting partner. Rep–NPM interactions were verified by co-immunofluorescence and chemical cross-linking studies. We have found
that there is demonstrable, but limited co-localization between Rep and NPM in co-infected cells. In contrast, there was significant co-localization
between NPM and AAV Cap proteins. In vitro experiments using purified MBPRep78 and NPM show that NPM stimulates MBPRep78
interactions with the AAV ITR as well as endonuclease activity. These studies suggest that NPM plays a role in AAV amplification affecting Rep
function and virion assembly.
© 2006 Elsevier Inc. All rights reserved.Keyword: AAV–Nucleophosmin co-localizationIntroduction
Adeno-associated virus (AAV) is a non-pathogenic mem-
ber of the Parvovirus family and the Dependovirus genus
(Muzyczka and Berns, 2001). As a Dependovirus, AAV needs
another virus, such as adenovirus, to efficiently replicate inside
a host cell. AAV has a linear single-stranded DNA genome of
4780 nucleotides (Muzyczka and Berns, 2001). The genome
contains two translation open reading frames (ORF) encoding
three structural and four non-structural proteins and is flanked at
both ends by inverted terminal repeat (ITR) sequences that serve
as origins of replication (Lusby et al., 1980; Srivastava et al.,
1983). The ORF on the left side encodes four non-structural
proteins, or replication (Rep) proteins designated Rep78,⁎ Corresponding author. Fax: +1 419 383 6228.
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doi:10.1016/j.virol.2006.07.050Rep68, Rep52 and Rep40 based on their apparent molecular
weight in SDS-PAGE gels (Mendelson et al., 1986). Rep78 and
Rep68 are translated from mRNAs originating from a
transcription promoter at map unit 5 (p5). Rep52 and Rep40
are translated from mRNAs originating from a transcription
promoter at map unit 19 (p19). Rep68 and Rep40 differ from
Rep78 and Rep52 as a result of mRNA splicing that replaces 92
amino acids from the carboxyl terminus with 9 amino acid
residues. Rep78/68 are required for viral DNA replication,
regulation of AAV gene expression and site-specific integration
into human chromosome 19, which occurs in the absence of
helper virus infection (Kotin et al., 1990). The smaller Rep
proteins, Rep52/40, play roles in virus assembly (Chejanovsky
and Carter, 1989; King et al., 2001). Rep78 and Rep68 both
interact with a Rep-binding site (RBS) found in the A-stem of
the AAV ITR. Both larger Rep proteins also possess ATPase,
helicase and site-specific strand-specific endonuclease activ-
ities that are important for viral replication (Chiorini et al.,
1994; Im and Muzyczka, 1990, 1992). Rep52 and Rep40 are
not endonucleases but share Rep78/68's ATPase and helicase
Table 1
Rep68 interacting partners a
HMG-1
SET/TAF-1
Acidic Leu-rich nuclear phosphoprotein 32 family member (Anp32)
Nucleolin (C23)
Nucleophosmin (B23/NPM)
a Hela nuclear extracts were passed over an Rep68 column. Adherent proteins
were eluted with KCl, separated by SDS-PAGE and identified by mass
spectrometry.
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and Kotin, 1998). Rep78 and Rep68 also have DNA ligase
activity (Smith and Kotin, 2000). Since there is extensive
sequence identity, the two large or two small Rep proteins are
nearly interchangeable in terms of function (Collaco et al.,
2003; Im and Muzyczka, 1990, 1992; Smith and Kotin, 1998).
Three structural, or capsid (Cap or VP), proteins are encoded on
the right side of the genome. A transcription promoter at map
unit 40 (p40) directs the transcription of differentially spliced
mRNAs that are translated into the three structural proteins
VP1–3.
AAV and Ad replicate and assemble their genomes in the
nucleus of the co-infected cell. AAV Rep and Cap proteins co-
localize with the Ad, E2a, single-stranded DNA binding protein
in replication centers (Hunter and Samulski, 1992; Weitzman et
al., 1996). AAV capsid proteins also localize in the nucleolus at
early stages of infection, and Rep protein expression is required
for capsid proteins to leave the nucleolus (Wistuba et al., 1997).
Furthermore, Rep proteins transiently exist in the nucleolus
(Wistuba et al., 1997). While searching for cellular factors that
interact with AAV Rep proteins, we observed in vitro asso-
ciations with the abundant nucleolar protein B23/Nucleophos-
min (NPM).
NPM is a nucleolar protein with many functions (Okuda,
2002). NPM is involved in ribosome biogenesis (Savkur and
Olson, 1998; Yung et al., 1985), duplication of centrosomes
(Okuda, 2002; Okuda et al., 2000) and shuttling of proteins to
the nucleus (Szebeni et al., 1995, 1997 and has chaperone
protein characteristics (Szebeni et al., 2003; Szebeni and Olson,
1999). Two forms of the protein, referred to as B23.1 and B23.2,
arise from differential splicing of mRNA. B23.1, and to a lesser
extent B23.2, has ribonuclease activity that can cleave tRNA
and mRNA but has specificity for rRNA (Herrera et al., 1995;
Savkur and Olson, 1998). Only B23.1 nonspecifically binds to
single-stranded DNA, double-stranded DNA and RNA (Dum-
bar et al., 1989; Herrera et al., 1996; Wang et al., 1994). The
B23/NPM gene is often targeted in chromosomal translocations
associated with acute myeloid leukemia (AML) resulting in
expression of oncogenic NPM fusion proteins (Redner, 2002;
Yoneda-Kato et al., 1996). NPM exerts other effects on cell
proliferation in that it associates with Rb, p53 HDM2 and
p14ARF (Bertwistle et al., 2004; Colombo et al., 2002; Kurki et
al., 2004b; Takemura et al., 1999). These associations are
believed to play pivotal roles in cellular DNA damage response
and cancer (Kurki et al., 2004a).
Using co-immunofluorescence and co-immunoprecipita-
tions, we demonstrate that a portion of the AAV Rep protein
in the co-infected cell associates with NPM in intact nucleoli and
in punctate extra-nucleolar structures in the infected nucleus. At
early stages of infection, Cap proteins are found in punctate
replication/assembly structures that are affiliated with NPM.
Using purified Rep78/68 and NPM proteins, we demonstrate
that NPM stimulates Rep-specific binding to the AAV ITR and
site-specific endonuclease activities. Our observations that NPM
associates with the AAVCap and Rep proteins expand the cast of
NPM-interacting partners and provide new insights into the
AAV replication cycle.Results
Identification of cellular Rep-interacting partners
The wide array of functions performed by the Rep proteins
during AAV infection suggests that these relatively small
proteins must interact with cellular proteins to facilitate the virus
amplification cycle. Most of the studies that have identified
Rep-interacting partners have used yeast two-hybrid method-
ologies. We chose a different approach resulting in the
identification of several novel partners. Rep68, purified from
E. coli, was covalently attached to CnBr-activated sepharose
to form a Rep-column. HeLa nuclear extracts were prepared and
fractionated over the column followed by several wash steps to
eliminate nonspecific binding. Proteins were eluted from the
column in 1 M KCl and separated by SDS-PAGE. The gel was
stained with Coomassie, gel fragments excised and treated with
trypsin to elute peptides for mass spectrometry identification
(Table 1). One of the proteins that interacted with the Rep68
column was nonhistone HMG-1. Detection of HMG-1 validates
our approach because it has already been identified as a Rep-
interacting partner (Costello et al., 1997). The SET/TAF-1 and
Anp32 proteins are members of the acidic leucine-rich nuclear
phosphoprotein 32 (Anp32) family of protein phosphatase 2A
(PPP2, formerly PP2A) inhibitors (Santa-Coloma, 2003). SET/
TAF-1 has also been identified as a Rep-interacting partner that
stimulates AAV replication (Pegoraro et al., 2006). SET/TAF-1
is also a phosphatase inhibitor that is reported to be necessary
for Ad DNA replication in vitro (Matsumoto et al., 1995).
Nucleolin (C23) and NPM are nucleolar proteins. C23 interacts
with NPM and has roles in ribosomal synthesis, can act as a cell
surface receptor, and along with NPM, shuttle proteins from the
cytoplasm to the nucleus (Li et al., 1996; Srivastava and Pollard,
1999). A role for C23/nucleolin in AAVamplification has been
suggested because it was co-purified with intact AAV2 capsid
(Qiu and Brown, 1999).
NPM is not known to play any role in AAV replication.
However, NPM is involved in the replication cycles of other
viruses. NPM is redirected to adenovirus replication centers
during adenovirus infection and NPM is also important in in
vitro DNA replication of the Ad genome (Matthews, 2001;
Okuwaki et al., 2001a; Walton et al., 1989). The nucleolus is
important for the replication of the related Parvovirus, minute
virus of mice (MVM) (Walton et al., 1989). NPM associates
with HTLV-1 Rex, HIV-1 Rev and hepatitis delta antigens
(Adachi et al., 1993; Fankhauser et al., 1991; Huang et al.,
104 J.M. Bevington et al. / Virology 357 (2007) 102–1132001). Given NPM's role in the replication cycle of other
viruses and its involvement in the cellular DNA damage
response, we investigated its interactions with AAV proteins.
NPM co-localization with Cap and Rep proteins
During the early–middle stages of AAVand Ad co-infection,
Rep proteins localize to punctate replication centers in theFig. 1. Co-localization of NPM and AAV proteins. HeLa cells were co-infected with A
(G–I) and fixed 20 to 30 h post-infection. Fixed cells were stained for AAV Rep (A),
yellow or white spots. Fixed cells were also stained for: Ad hexon protein (G and J)
Nuclei were stained with DAPI and are depicted in blue in the merged images (C, F, I
AAV- and Ad-infected HeLa cells (M–P). Immunofluorescent staining of Cap (M and
Panels M–P and O–P are of the same field respectively and are separated by 1.5 μm. Y
(For interpretation of the references to colour in this figure legend, the reader is refenucleus and co-localize with Cap proteins (Hunter and
Samulski, 1992; Weitzman et al., 1996; Wistuba et al., 1997).
As replication progresses, the Rep and Cap proteins spread
throughout the nucleus (Weitzman et al., 1996; Wistuba et al.,
1997). Co-immunofluorescence experiments were conducted to
determine if Rep and NPM proteins co-localize in AAV- and
Ad-co-infected HeLa cells. Immunofluorescence with anti-Rep
showed staining throughout the nucleus as well as in punctated5 (10 m.o.i.) and AAV2 (250 m.o.i.) (A–F and J–L) or infected with Ad5 alone
Cap (D) and NPM (B and E). Merged images (C and F) show co-localization as
, NPM protein (H), and AAV Cap (K). These images are also merged (I and L).
and L). Scale bar is equivalent to 15 μm. Confocal microscopy was performed on
N) and Rep (O and P) is shown in green. NPM staining (M–N) is shown in red.
ellow staining is the result of image merging and is indicative of co-localization.
rred to the web version of this article.)
105J.M. Bevington et al. / Virology 357 (2007) 102–113nuclear regions (Fig. 1A). Merging Rep- and NPM-stained
images showed limited areas of co-localization (Fig. 1C). A
minority of the cells that are Rep positive have some degree of
co-localization between Rep and NPM at early stages of
infection. Staining with AAVanti-Cap showed similar punctate
structures (Fig. 1D). However, merged Cap- and NPM-stained
images showed a much greater degree of co-localization (Fig.
1F). All of the cells that had punctate Cap staining also had co-
localized NPM staining. Moreover, all of the punctate, Cap-
stained structures also showed NPM staining. As a negative
control for these experiments, co-infected cultures were stained
for NPM and Ad hexon protein (Figs. 1G–I). Ad hexon is the
most abundant outer structural protein. We also stained for AAV
Cap and hexon (Figs. 1J–L). There was no detectable co-
localization of NPM with hexon and only diffuse nuclear and
cytoplasmic co-localization between Cap and hexon.
The results shown in Figs. 1A–L were obtained with a stan-
dard immunofluorescence microscope. To more conclusively
demonstrate that Rep and Cap co-localize with NPM, confocal
microscopy was used. Figs. 1M and N are from the same field,
and the images are separated by 1.5 μm. Co-localization of Cap
and NPM is demonstrated by the yellow color in these images. It
is clear that all of the nucleoli and punctate structures
demonstrate co-localization. Panels O and P show Rep and
NPM staining with co-localization in the swollen nucleoli and in
the punctate structures. These results are consistent with the
results shown in the first part of Fig. 1 but provide more
convincing evidence of co-localization.
NPM staining in AAV- and Ad-co-infected cells was found
in two structures, numerous small punctate dots throughout the
nucleus and large rounded structures that appear to be swollen
nucleoli (Figs. 2B–D). These structures suggest that nucleoli
are remodeled in the co-infected cell. The punctate structures
were often smaller than normal nucleoli, and we have observedFig. 2. Nucleolar remodeling during AAVand Ad co-infection. AAV- and Ad-co-infec
were fixed 20 p.i. NPM was stained with AlexaFlour568 (A–D) or FITC (E–H). A
stained with AlexaFlour568 (F–H). AlexaFlour568 is a red fluorophore, whereas FIT
DAPI. Swollen nuclei and small punctate subnuclear structures are evident in pane
interpretation of the references to colour in this figure legend, the reader is referredas many as fifty per nucleus (Fig. 2D). Cells infected with Ad
alone will often have multiple nucleoli-like structures, but they
are not as numerous as those seen in AAV- and Ad-co-infected
nuclei. Swollen nucleoli have been described previously
(Wistuba et al., 1997). These nucleoli are enlarged in Rep-
expressing infected cells and had a more intense fluorescence as
compared to uninfected (Rep-negative) cells (Wistuba et al.,
1997). Cap co-localization in the swollen nucleoli was observed
throughout the structure (Figs. 1F, M and N). Nearly all of the
punctate structures stain with both NPM and Cap antibodies,
suggesting that these may be sites of capsid assembly. Ad-
infected cells did not show the abundant sub-nucleolar, NPM-
stained structures (Figs. 2F–H).
AAV Cap, Rep and NPM association detected by chemical
cross-linking and immunoprecipitation
To further investigate if there is a physical interaction
between AAV proteins and NPM, we co-immunoprecipitated
these proteins with specific antibodies. Our initial attempts to
detect an association between NPM and the AAV Rep proteins
using co-immunoprecipitations from AAV- and Ad-co-infected
cells were unsuccessful, therefore we used dithiobis (succini-
midyl) propionate (DSP) to chemically cross-link weakly inter-
acting proteins. Nuclei were isolated from virus-infected
cultures and cross-linked with DSP. Nuclear extracts were
prepared and immunoprecipitated with antisera against Rep, Cap
and NPM. The cross-links were reversed and proteins separated
by gel electrophoresis and immunoblotted. When extracts were
immunoprecipitated with anti-Rep, NPM was co-immunopreci-
pitated from the co-infected culture, but only when chemically
cross-linked (Fig. 3A, lane 5). NPM was not precipitated from
the uncross-linked extracts (Fig. 3A, lane 4). Conversely,
Rep proteins were co-immunoprecipitated with anti-NPMted HeLa cells (B–D), Ad infected HeLa cells (F–H) and uninfected cells (A, E)
AV Cap proteins were stained with AlexaFlour488 (B–D), and Ad hexon was
C and AlexaFlour488 are green fluorophores. Nuclei were counterstained with
ls B–D. All panels are merged images. Scale bar is equivalent to 15 μm. (For
to the web version of this article.)
Fig. 3. Co-immunoprecipitation of NPM and AAV proteins. Ad- or Ad- and
AAV-co-infected HeLa cells were harvested 22 h post-infection, nuclei were
isolated and chemically cross-linked with 2 mM DSP. Antibodies to Rep and
NPMwere used for immunoprecipitation, the cross-linked were reversed and the
precipitates separated by SDS-PAGE. The separated proteins were analyzed by
Western blot using NPM, Rep or Cap antibodies. The extracts (Ext.) used were
from Ad-infected (Ad) or AAV- and Ad-co-infected (Co) cells. The use of the
DSP cross-linking agent (XL) is indicated by ‘+’ or ‘−’. Lanes 1 and 2 in each
panel are crude extracts loaded on the gel without prior immunoprecipitation.
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tion was observed without cross-linking (Fig. 3B, compare lanes
4 and 5). To detect Cap and NPM interactions, infected extracts
were immunoprecipitated with anti-NPM. This experiment
showed that NPM antibody co-imunoprecipitated AAV struc-
tural proteins from both untreated and cross-linked co-infected
nuclear extracts (Fig. 3C, lanes 4 and 5). We have been unable to
co-immunoprecipitate NPM with either a polyclonal anti-Cap
antibody obtained from denatured VP3 or the A20 monoclonal
antibody that recognizes native capsid (results not shown).
These results demonstrate a close association, if not a physical
interaction, between NPM and AAV proteins.NPM stimulates MBPRep78 binding to the AAV ITR RBS
Immunofluorescence and chemical cross-linking showed co-
localization and close association between Cap and NPM
proteins. Since Rep proteins associate with the maturing virion
via noncovalent interactions, and covalently, via linkage to the
5′ end of the viral DNA, it is not possible to determine if there is
a direct interaction between NPM and the Rep proteins. In vitro
EMSA analyses were performed to investigate potential Rep–
NPM interaction. AAV Rep78/68 proteins interact with the RBS
found in the A-stem of the AAV ITR element (Muzyczka and
Berns, 2001). An A–D stem DNA fragment was radiolabeled
and incubated with purified MBPRep78 and NPM. Fig. 4 shows
that NPM stimulated MBPRep78 binding to a DNA probe
containing its cognate binding site. Both a His-tagged and a
GST-tagged NPM stimulated MBPRep78 binding. Thus, the
increased binding does not depend on the tag used to purify
NPM (Fig. 4A; compare lanes 5 and 6 to lane 4). Although
NPM stimulated binding, no new complexes were observed.
This suggests that NPM stimulated binding in a transient manner
and that the chaperone activity of NPM may be involved in this
binding.
NPM did not show any detectable binding to AAV DNA by
itself (Fig. 4A, lanes 2 and 3) even though it nonspecifically
binds to DNA (Dumbar et al., 1989; Wang et al., 1994). A
probable reason for this is that conditions used in this
experiment were not optimal for NPM binding to DNA since
NaCl concentration in the buffer was 0.05 M and NPM binds to
DNA at lower salt concentrations (Dumbar et al., 1989; Herrera
et al., 1996; Wang et al., 1994).
To further demonstrate the enhanced binding of MBPRep78,
a dose–response assay was performed with increasing amounts
of NPM or BSA. Fig. 4B shows that, with increasing concen-
trations of NPM, MBPRep78 interaction with the AAV RBS
increases. However, BSA did not stimulate binding (Fig. 4C).
Similar molar ratios of MBPRep78 to BSAwere used in EMSA
assays to verify that NPM stimulation, rather than an
unspecified stimulatory effect, results in increased MBPRep78
binding. This verifies that increased binding of MBP-Rep78 is
dependent upon NPM.
Increased Rep-mediated nicking at the AAV trs site with NPM
Rep78 or Rep68 interaction with the AAV ITR is required for
site-specific nicking of the covalently closed end of the viral
genome. Upon binding and oligomerization, Rep78 or Rep68
make a site-specific, strand-specific nick in the terminal
resolution site (trs) enabling completion of DNA synthesis at
the ends of the viral DNA. To determine if NPM affects Rep-
mediated nicking, endonuclease assays were performed with
increasing amounts of NPM or BSA. Purified MBPRep78 and
GSTNPM were incubated with a radiolabeled 182 nt ITR
endonuclease substrate. Fig. 5A shows that increasing amounts
of NPM stimulate nicking, yielding the appropriate, 73 nt
product. Equimolar concentrations of BSA had no effect on
MBPRep78 nicking (Fig. 5B). This result is consistent with the
EMSA analyses because stimulation of binding to the A–D
Fig. 4. NPM stimulates MBPRep78 interaction with the AAV ITR. A 65-bp DNA fragment from the A–D component of the AAV ITR was radiolabeled and incubated
with NPM and MBPRep78 (designated Rep78 in the figure). Protein–DNA complexes were separated by non-denaturing gel electrophoresis and exposed to X-ray
film. (A) 3.4 nMMBPRep78 was used in lanes 4, 5 and 6, 14.3 nM GSTNPM was used in lanes 2 and 5 and 13.8 nM HisNPM was used in lanes 3 and 6. (B) 8.9 nM
MBPRep78 was used in lanes 3 to 8, and 4.7, 9.4, 18.7, 37.5, 74.9 and 93.5 nM GSTNPM were used in lanes 4, 5, 6, 7, 8 and 2, respectively. (C) 3.4 nM MBPRep78
was used in lanes 3 to 8. 1.8, 3.5, 7, 14, 28 and 28 nM of BSA were used in lanes 4, 5, 6, 7, 8 and 2, respectively. Equimolar amounts of BSA:MBPRep78 and
GSTNPM:MBPRep78 were used in the respective lanes (lanes 4 to 8) of panels B and C.
107J.M. Bevington et al. / Virology 357 (2007) 102–113oligonucleotide would be expected to result in increased nicking
activity.
Discussion
The minimal coding capacity of the Parvovirus genome
dictates that numerous cellular proteins are required to support
virus amplification. Several cellular proteins have been
identified that interact with AAV proteins. Most of the proteins
that interact with Rep play roles in mRNA transcription. Rep78/
68 interact with: Sp1 (Hermonat et al., 1996; Pereira and
Muzyczka, 1997), HMG-1 (Costello et al., 1997), the transcrip-Fig. 5. NPM stimulates MBPRep78 endonuclease activity. MBPRep78
(1.34 nM, designated Rep78) was incubated with radiolabeled ITR with ATP
to induce endonuclease activity. The reactions were separated by denaturing
polyacrylamide gel electrophoresis and exposed to X-ray film. (A) Lanes 4, 5, 6,
7 and 2 contain to 0.8, 4, 20, 40 and 61 nM of HisNPM, respectively. (B) Lanes
3, 4, 5, 6 and 1 contain 0.8, 4, 20, 40 and 60 nM of BSA, respectively.tional co-activator PC4 (Weger et al., 1999), TATA binding
protein (Hermonat et al., 1998; Needham et al., 2006), the p53
and topoisomerase binding protein, Topors (Weger et al., 2002),
a putative protein kinase, protein kinase X (PKX) and protein
kinase A (PKA) (Chiorini et al., 1998; Di Pasquale and Chiorini,
2003). The biological effect of the PKX association is inhibition
of the steady-state levels of cAMP-responsive-element-binding
protein (CREB) and cyclin A protein. Nucleolin, also known as
C23, co-purifies with AAV2 and was found to associate with
intact AAV2 capsid by immunoprecipitation and immuno-
fluorescence techniques (Qiu and Brown, 1999). C23/nucleolin
is a ubiquitous nucleolar protein implicated in nuclear
transport, organization of nucleolar chromatin, packaging of
pre-RNA, rDNA transcription and ribosome assembly (Srivas-
tava and Pollard, 1999). Thus, there are only a limited number
of cellular proteins known to interact with AAV-encoded
proteins.
To identify additional cellular proteins that interact with
Rep78/68, we attached purified Rep68 to activated sepharose
creating a Rep affinity chromatography resin. HeLa nuclear
extracts were passed over the column and eluted with high salt.
Mass spectrometry analyses identified several new potential
Rep partners. One of the proteins identified was HMG-1. This
observation verifies the validity of our approach because
HMG-1 has already been identified as a Rep-interacting partner
(Costello et al., 1997). Two of the identified proteins are
involved in protein phosphatase activity: protein SET/TAF-1
and Anp32. The SET/TAF-1 and Anp32 proteins are members
of the acidic leucine-rich nuclear phosphoprotein 32 family of
protein phosphatase 2A (PPP2, formerly PP2A) inhibitors
(Santa-Coloma, 2003). SET/TAF-1 was first identified as a gene
fused to the CAN gene in a patient with acute undifferentiated
leukemia (von Lindern et al., 1992). SET was subsequently
found to be identical to template activation factor I (TAF-1), a
cellular protein necessary for DNA replication of the Ad
genome in vitro (Matsumoto et al., 1995). C23/nucleolin and
B23/NPM were also identified. Recently, SET/TAF-1 was
108 J.M. Bevington et al. / Virology 357 (2007) 102–113shown to be a Rep-interacting partner that regulates AAV DNA
replication (Pegoraro et al., 2006). We focused on NPM because
of its wide array of functions in normal and transformed cells.
B23/NPM is a nucleolar protein with many proposed
functions (Okuda et al., 2000). It exists in two forms, B23.1
and B23.2, which are nearly identical except at the C-terminal
end (Chang and Olson, 1989, 1990). The protein sequence is
highly conserved among rat, mouse and human. B23.2, which is
the alternatively spliced form of B23.1, replaces 36 amino acids
at the C-terminus of B23.1 with 2 amino acids (Chang and
Olson, 1989, 1990). The more abundant B23.1 protein exists
predominantly in the nucleolus (Okuwaki et al., 2002; Wang
et al., 1993). NPM has a variety of proposed functions including
ribosome biogenesis (Okuwaki et al., 2002; Savkur and Olson,
1998; Yung et al., 1985), histone chaperone (Okuwaki et al.,
2001b), duplication of centrosomes (Okuda, 2002; Okuda et al.,
2000), shuttling proteins to the nucleus (Borer et al., 1989;
Szebeni et al., 1995, 1997, 2003) and has general chaperone
protein characteristics (Szebeni and Olson, 1999). B23.1, and to
a lesser extent B23.2, has ribonuclease activity that cleaves
tRNA and mRNA but has specificity for rRNA (Herrera et al.,
1995; Savkur and Olson, 1998). Only B23.1 nonspecifically
binds to single-stranded DNA, double-stranded DNA and RNA
(Dumbar et al., 1989; Herrera et al., 1996; Wang et al., 1994).
NPM has also been implicated in the initial cellular response to
environmental stressors. DNA damaging agents such as UV
light induces expression (Weber et al., 2000) and nuclear re-
localization of NPM (Kurki et al., 2004a) thus stimulating DNA
repair and escape from apoptosis (Wu et al., 2002). NPM is part
of a large protein complex that includes the p53 tumor sup-
pressor HDM2 and p19Arf (Colombo et al., 2002; Itahana et al.,
2003; Korgaonkar et al., 2005; Kurki et al., 2004b). NPM
increases the stability and transcriptional potential of p53 via its
chaperone activity and inhibition of Mdm2 ubiquitin ligase
activity (Colombo et al., 2002; Kurki et al., 2004b).
Our co-immunofluorescence and chemical cross-linking
studies demonstrate that NPM is found in close proximity to
AAV Rep and Cap proteins. Intra-nuclear Cap and NPM co-
localization was prevalent with domains showing high
concentrations of Cap enriched in NPM. However, Rep and
NPM co-localization was not as prevalent as that observed with
Cap proteins. Immunofluorescence using confocal microscopy
further substantiated the hypothesis that AAV proteins co-
localize with NPM. From our chemical cross-linking experi-
ments, the relatively short length of the DSP cross-linker (12 Å)
suggests that NPM exists in close proximity to Cap or Rep
proteins. Since Rep proteins associate with the virion or viral
DNA by noncovalent and covalent interactions, respectively
(Dubielzig et al., 1999; Prasad and Trempe, 1995), it is not
possible to verify that NPM directly interacts with both viral
proteins in the co-infected cell. That AAV Cap proteins are co-
immunoprecipitated with anti-NPM from non-cross-linked
extracts suggests that there is a stronger affinity between these
proteins than between NPM and Rep. Our inability to co-
immunoprecipitate NPM with Cap-specific antibodies suggests
that NPM interactions may block the structural epitopes
required for immunoprecipitations.We performed in vitro studies with purified Rep and NPM to
further investigate whether these proteins interact. NPM
stimulated MBPRep78 interactions with the AAV ITR and
Rep endonuclease activity. NPM by itself did not interact with
the ITR, even though it has DNA binding ability. NPM purified
as either a His-tagged and GST-tagged fusion protein stimulated
ITR binding. Neither version of the protein appeared to become
part of the MBPRep78–ITR complex in that no new species
were found in the EMSA. Stimulation of MBPRep78 binding to
the ITR would be expected to result in increased endonuclease
activity as we observed here. Although NPM stimulated
MBPRep78–ITR binding and endonuclease activities, it did
not stimulate Rep-specific ATPase activity (data not shown).
These experiments suggest that NPM stimulates Rep binding
via its chaperone activity (Szebeni and Olson, 1999). In the
infected cell, NPM may also interact with Rep in a transient
manner.
It will be interesting to determine which region of the Rep
proteins is responsible for the interaction with Nucleophosmin
(it is presumably not the C-terminus since both Rep 68 and 78
interact) and if mutant studies will yield an idea of the
significance of the Rep–Nucleophosmin interaction.
Early in infection Rep proteins are primarily nuclear and are
observed in a punctate pattern. As infection progresses, Rep
proteins pass transiently through the nucleolus followed by co-
localization with AAV DNA as demonstrated by in situ
hybridization. Cap proteins also transiently pass through the
nucleolus. AAV DNA, Rep and Cap proteins co-localize in
punctate replication/encapsidation centers (Hunter and
Samulski, 1992; Weitzman et al., 1996; Wistuba et al., 1997).
Expression of the AAV Cap gene in the absence of Rep or AAV
DNA replication in HeLa cells resulted in Cap enrichment in the
nucleolus (Weger et al., 1997; Wistuba et al., 1997). It has been
proposed that Rep expression may be required for assembled
capsid to escape the nucleoli (Wistuba et al., 1997). An
interesting observation from the immunofluorescence studies
is the apparent nucleolar remodeling that occurs in AAV- and
Ad-co-infected cells. In addition to the appearance of swollen
nucleoli, there were numerous punctate structures that were
smaller than nucleoli from uninfected cells. The near total
congruence of Cap and NPM staining in these structures
suggests that capsid assembly and/or genome encapsidation may
occur at these sub-nucleolar structures.
It is unclear which of the numerous functions of NPM is
involved in AAVamplification. Our in vitro studies suggest that
the NPM chaperone activities may play a role in Rep protein
function in vivo. A transient interaction between Rep and NPM
may also be reflected in the minimal co-localization between
these proteins observed in our co-immunofluorescence studies.
The prevalence of NPM and Cap co-localization suggests that
these proteins are more intimately involved. The accumulation
of Cap proteins in the nucleolus in the absence of Rep protein or
AAV DNA suggests that capsid assembly occurs in the
nucleolus (Wistuba et al., 1997). Our results, and those
described above, support a model of AAV assembly in which
Cap proteins accumulate and assemble in the nucleolus where
they associate with NPM and perhaps other nucleolar proteins.
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Rep–Cap–NPM complexes from the nucleolus and into the
nucleoplasm where viral DNA encapsidation occurs. Little is
known about AAV capsid assembly in vivo (Timpe et al., 2005).
It will be informative to determine if NPM plays a role in AAV
assembly.
Methods
Cells and virus preparation
HeLa cells (American Type Culture Collection) were grown
as a monolayer at 37 °C (5% CO2 atmosphere) in Eagle's
minimum essential medium (MEM) supplemented with 10%
(v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 25 U/mL
penicillin, 25 μg/mL streptomycin, 2.5 μg/mL amphotericin B
and 100 μg/mL gentamicin. AAV2 and Ad5 were prepared by
the method previously described (Casper et al., 2005; Winters
and Russell, 1971).
Protein purification
An amino-terminal His6 tagged NPM (B23.1 version) in a
pQE30 prokaryotic expression vector (pHis-B23.1) in
SG13009 cells was kindly provided by Dr. Mark Olson
(Umekawa et al., 2001). A 5 mL overnight Luria-Bertani
(LB) starter culture was used to inoculate a 1 L LB culture
and incubated at 37 °C until an A600 of ∼0.6 was reached.
The culture was induced with 1 mM IPTG for 2.5 h at 37 °C.
The cells were pelleted at 9000×g for 15 min at 4 °C and
then washed once with 30 mL phosphate buffered saline
(PBS). Cells were pelleted again at 9000×g for 10 min at 4 °C.
Cells were lysed in 20 mL of lysis buffer (50 mM NaPO4,
500 mM NaCl, 10 mM imidazole, 1 mM β-mercaptoethanol,
40 μg/mL lysozyme, pH 8.0) on ice for 20 min. Cells were
sonicated using a Fisher Sonic Dismembrator 550 on ice level
3 with 1 min on and 10 s off three times. The lysate was
pelleted for 10 min 12,000×g at 4 °C. The supernatant was
applied to 0.5 mL column of Ni-NTA Superflow (Qiagen)
equilibrated in lysis buffer. The column was washed with nine
column volumes of cold wash buffer (50 mM NaPO4,
500 mM NaCl, 50 mM imidazole, 1 mM β-mercaptoethanol,
pH 8.0). HisNPM was eluted off the column with cold elution
buffer (50 mM NaPO4, 500 mM NaCl, 250 mM imidazole,
1 mM β-mercaptoethanol, pH 8.0). The purified protein was
dialyzed overnight in 20 mM Tris pH 8.0, 10% glycerol,
200 mM NaCl.
An amino-terminal glutathione-S-transferase (GST) tagged
B23.1 (GSTNPM) prokaryotic expression vector (pGST-B23.1)
was constructed as follows. The B23.1 cDNAwas excised from
pHis-B23.1 with BamHI and inserted into the BamHI multi-
cloning site of the pGEX-6P-2 (Amersham Biosciences) vector.
For protein expression, BL21 Star (DE3) was transformed with
the plasmid. Purification of GSTNPM was as follows. A 5 mL
overnight LB starter culture was used to inoculate a 250 mL LB
culture and incubated at 37 °C until an A600 of ∼0.6 was
reached. The culture was induced with 1 mM IPTG for 2.5 h at37 °C. The cells were pelleted at 10,000×g for 10 min at 4 °C
and then washed once with 30 mL PBS. The pellet was
resuspended in 5 mL cold PBS. The cells were lysed using a
Fisher Sonic Dismembrator 550 on ice level 4 for 30 s. Triton
X-100 was added for a final concentration of 1%. The lysate
was pelleted for 5 min 4 °C at 16,000×g. The supernatant was
added to 1 mL of 50% glutathione–agarose (Sigma) bead slurry.
The 50% glutathione–agarose bead slurry was prepared
following manufacturers' instructions. The protein extract was
mixed with the slurry for 2 min at 4 °C. The beads were pelleted
at 500×g for 1 min at 4 °C. The bound protein was washed
twice with 50 mL cold PBS+1 M NaCl and then twice with
50 mL cold PBS. GSTNPM was eluted with 500 μL cold
50 mM Tris pH 7.5+5 mM reduced glutathione. Glycerol was
added for a final concentration of 10%.
An amino-terminal His6 tagged Rep68 (HisRep68) in a
pQE70 prokaryotic expression vector was kindly provided by
Dr. R.J. Samulski (Young et al., 2000). Purified bacterially
expressed HisRep68 was prepared as described previously
(Casper et al., 2005).
An amino-terminal maltose binding protein (MBP) tagged
Rep78 (MBPRep78) in a pPR997 prokaryotic expression vector
was kindly provided by Dr. R.M. Kotin (Chiorini et al., 1994).
Purified bacterially expressed MBPRep78 was prepared as
described previously (Needham et al., 2006).
Rep-column chromatography
HisRep68 was attached to the activated CNBr-sepharose
(Sigma catalog #C5338) by the procedure described by the
manufacturer with slight modifications. 1.5 mg of HisRep68 in
1 mL volume was dialyzed for 4 h in 100 mL of 100 mM
NaHCO3, 500 mM NaCl, pH 8.3. The buffer was discarded and
dialysis continued for 2 h in 100 mL fresh buffer. The CNBr-
resin was prepared by swelling in 1 mM HCl, washed with
distilled water and then with coupling buffer (0.1 M NaHCO3,
0.5 M NaCl, pH 8.3). HisRep68 from dialysis was added
immediately to 300 μL of the prepared resin and allowed to
rotate overnight at 4 °C. The following day the resin was
washed twice in cold coupling buffer and then mixed for 2 h
with blocking buffer (100 mM Tris–Cl, 500 mM NaCl, pH
8.0). The blocking buffer was washed away and the resin was
equilibrated in HeLa extract Buffer D (20 mM HEPES pH 7.9,
100 mM KCl, 0.2 mM EDTA, 20% glycerol). HeLa nuclear
extracts were prepared following the method described
(Dignam et al., 1983). To look for Rep-interacting proteins,
400 μL of HeLa nuclear extract (in Buffer D) was mixed with
100 μL of the Rep-column resin and rotated at 4 °C for 2 h. The
resin was allowed to settle, and the supernatant was removed.
The resin was washed three times with 1 mL of Buffer D
+300 mM KCl and the supernatant saved. This was followed
by a wash of 250 μL of Buffer D+500 mM KCl and 250 μL of
Buffer D+1 M KCl. Samples of these fractions were separated
by SDS-PAGE gels and silver stained. Fractions of interest
were separated by SDS-PAGE and stained with colloidal
Coomassie G-250. Bands were cut from the gel and sent for
mass spectrometry analysis.
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The proteins were separated on SDS-PAGE and visualized
with colloidal Coomassie stain (Invitrogen). Protein bands were
excised and destained with 30% methanol for 3 h at RT. In gel
proteolysis with modified, sequencing grade trypsin (Promega,
Madison, WI) was carried out essentially as described pre-
viously (Basrur et al., 2003). Briefly, gel slices were further
washed with 150 μL of 50% acetonitrile in 0.1 M ammonium
bicarbonate buffer, pH 8.0, for 30 min, trypsin (0.5 μg,
Promega) was added in a minimal volume of 0.1 M ammonium
bicarbonate buffer and the digestion was carried out for 16 h at
37 °C with an additional aliquot of trypsin (0.25 μg) added after
12 h. Peptides were extracted sequentially with 150 μL of 60%
acetonitrile containing 0.1% TFA for 30 min and 100 μL of
acetonitrile containing 0.1% TFA. All extracts were pooled and
concentrated using Vacufuge to a final volume of 15 μL. Two
microliters of the digest was separated on a reverse phase
column (Aquasil C18, 15 μm tip×75 μm id×5 cm Picofrit
column, New Objectives, Woburn, MA) using acetonitrile/1%
acetic acid gradient system (5–75% acetonitrile over 35 min
followed by 95% acetonitrile wash for 5 min) at a flow rate of
∼250 nL/min. Peptides were introduced into an in-line, ion trap
mass spectrometer (LCQ Deca XP Plus, ThermoFinnigan)
equipped with a nano-spray source. The mass spectrometer was
set for analyzing the positive ions and acquiring a full MS scan
and a collision induced dissociation (CID) spectrum on the most
abundant ion from the full MS scan (relative collision energy
∼30%). Dynamic exclusion was set to collect 3 CID spectra on
the most abundant ion and then exclude it for 3 min. Database
search against an indexed, non-redundant human protein
database was performed using TurboSEQUEST software
(BioworksBrowser v 3.0, ThermoFinnigan). CIDs which
showed Xcorr and μCn values of >2.0 and >0.2, respectively,
for a +2 charged peptide, were considered positive. All CID
spectra were also verified manually using the MS-Digest and
MS-Product provision of Protein Prospector (http://prospector.
ucsf.edu).
Immunofluorescence
Antibodies used in these experiments were as follows: rabbit
polyclonal antibody affinity purified against all four Rep
proteins (Trempe et al., 1987) and Cap proteins (data
unpublished), anti-nucleophosmin (Zymed cat.#32-5200), goat
polyclonal anti-hexon (American Research Products, Inc. cat.
#12-6235-1), goat anti-mouse AlexaFlour568 (Molecular
Probes cat.#A-11031), donkey anti-goat AlexaFlour568 (Mole-
cular Probes cat.#A-11057), donkey anti-rabbit AlexaFlour488
(Molecular Probes cat.#A21206), donkey anti-mouse FITC and
4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) (Mole-
cular Probes). HeLa cells were plated 24 h prior to infection at
1×104 cells/well in each well of an 8-chamber slide (LAB-TEK
Brand, Nalge Nunc International). Cells were infected or mock
infected for 1 h in 200 μL of 2% (v/v) FBS MEM medium
(supplemented with L-glutamine) with Ad5 and AAV2 at a
multiplicity of infection (m.o.i.) of 10 and 250, respectively.After 1 h, an equivalent amount of 18% (v/v) FBS MEM
medium (supplemented with L-glutamine and antibiotics) was
added to the cells. At 20–30 h, cells were washed twice with
PBS. Cells were then fixed and permeabilized with 100% cold
methanol for 10 min on ice and then air-dried for 10 min. The
slides were washed twice with 2% bovine serum albumin (BSA)
in PBS (BSA–PBS) and blocked in the same solution for
20 min. The slide chambers were removed leaving the gasket.
The slides were incubated in RIPA buffer (50 mM Tris pH 8,
150 mM NaCl, 0.5% deoxycholate, 0.1% SDS, 1% nonidet
P40) for 10 min and then washed three times with BSA–PBS.
Slides were incubated with primary antibody in BSA–PBS for
1 h followed by three washes with BSA–PBS. Slides were
incubated with secondary antibody in BSA–PBS for 1 h
followed by three washes with BSA–PBS. Nuclei were stained
with 150 nM DAPI for 5 min followed by three washes with
BSA–PBS. A final three washes with just PBS were performed
before removing the slide gasket and mounting the slide with
DAKO Fluorescent Mounting Medium (DAKO Corporation).
All antibody and wash incubations were done at room tempe-
rature. A Nikon eclipse E800 fluorescent microscope was used
for visualization of co-localization. A BioRad Radiance 2000
Laser Scanning system mounted on an Olympus BX51WI
microscope was used to confirm co-localization.
Cross-linking and immunoprecipitation
HeLa cells were grown in 150 mm plates to 95% confluence
and infected. The infection was performed in serum free medium
with Ad5 and/or AAV2 at an m.o.i. of 10 and 100, respectively.
After 2 h of incubation at 37 °C, the medium was replaced with
10% (v/v) FBS MEM supplemented with L-glutamine and
antibiotics. Twenty-two hours later, the cells were scraped from
the plate and spun down at 1500×g for 5 min at 4 °C. The
pelleted cells were washed twice with 5 ml cold PBS+5 mM
MgCl2. The washed pellets were re-suspended and incubated on
ice for 10 min in 500 μL cold Buffer A (10 mM HEPES (pH
7.8), 10 mM KCl, 1.5 mM MgCl2 0.4% Triton X-100, 0.34 M
sucrose, 10% (v/v) glycerol, 1 μM leupeptin, 1 μg/mL pepstatin
A, 1 mMPMSF). The lysate was pelleted at 1500×g for 5 min at
4 °C. The supernatant (cytoplasmic extract) was carefully
removed, the nuclear pellet was re-suspended in 500 μL cold
Buffer A+200 mM NaCl and vortexed for 5 s. Dithiobis
(succinimidyl) propionate (DSP) (Pierce Chemical Company)
dissolved in dimethyl sulfoxide (stock=50 mM) was added to
the re-suspended pellet to a final concentration of 2 mM and
vortexed for 5 s. This treated nuclear fraction was rotated for
20 min at room temperature. The cross-linking was stopped by
the addition of 50 mM glycine and further rotation for 10 min
at room temperature. EDTA was added to a final concentration
of 20 mM; the cross-linked nuclear fraction was vortexed
vigorously for 30 s and incubated on ice for 1 h. The lysed
cross-linked extract was sonicated using a Fisher Sonic
Dismembrator 550 on ice (level 4, one-second pulses, for
45 s). SDS was added (final concentration of 1% (wt/v)), and
the lysed extract was denatured at 65 °C for 10 min. Meanwhile,
for each immunoprecipitation, 75 μL of Immunopure protein A
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buffer (50 mM Tris (pH 8.0), 20 mM EDTA (pH 8.0), 150 mM
NaCl, 0.5% NP-40). The beads were rotated at 4 °C for 5 min,
pelleted at 500×g for 2 min and the supernatant was aspirated.
Five hundred microliters of IPP buffer was added to these
equilibrated beads followed by 100 μL of the earlier heat
treated, denatured extracts. The extracts were pre-cleared by
rotation for 1 h at 4 °C. The beads were then pelleted at 500×g
for 2 min, and the supernatant containing the cleared extracts
was carefully added to 75 μL of freshly equilibrated beads
(washed as above). Appropriate antibodies were added, and the
immunoprecipitation was performed by rotation at 4 °C for
16 h. The antibodies used in the immunoprecipitations were:
anti-NPM, anti-Rep and rabbit anti-Cap raised against dena-
tured VP3 (described above). The beads were pelleted (500×g
for 2 min at 4 °C) and washed three times with IPP buffer. The
proteins were eluted from the beads and cross-links broken by
the addition of loading buffer (1.5× SDS-PAGE Sample buffer,
10% (v/v) β-mercaptoethanol) and heating to 100 °C for
10 min. Eluted proteins were run on a 10% SDS-PAGE gel and
transferred to a nitrocellulose membrane (Immobilon-Fisher
Scientific Co.). Transferred proteins were Western blotted as
indicated and detected by chemiluminescence.
EMSA probe preparation
The A–D stem sequence used for Fig. 4B is as follows:
TCCAGGAACCCCTAGTGATGGAGTTGGCCACTCCCTC-
TCTGCGCGCTCGCTCGCTCACTGAGGC and Phos-GCCTCA-
GTGAGCGAGCGAGCGCGCAGAGAGGGAGTGGCCAA-
CTCCATCACTAGGGGTTCCTGGA (InvitrogenCustomPrimers).
The A–D stem sequence used for Figs. 4A and C is as follows:
CCTAGTGATGGAGTTGGCCACTCCCTCTCTGCGCGCT-
CGCTCGCTCACTGAGGC and Phos-GCCTCAGTGAGC-
GAGCGAGCGCGCAGAGAGGGAGTGGCCAACTCCAT-
CACTAGG (Invitrogen Custom Primers). Both A–D stem
sequences contain the Rep binding element (RBE) and the trs
nicking site (Chiorini et al., 1995; Muzyczka and Berns, 2001).
The oligos were annealed following the manufacturers' recom-
mendations. Briefly, the oligos were annealed together in a 50 μL
reaction (100 mM Tris pH 7.5, 500 mM NaCl, 50 mM EDTA),
which was heated in sand bath at 65 °C for 10 min and then
allowed to cool slowly to room temperature. One picomole of
annealed oligos was incubated with 20 U of T4 polynucleotide
kinase and 50 μCi [γ-32P] ATP. The reaction went 16 h 37 °C and
purified over a 1 mL G-25 Sephadex column in TE.
Electrophoretic mobility shift assay (EMSA)
EMSAs were performed following method previously
described (Needham et al., 2006). Briefly, the radiolabeled
A–D substrate was incubated in a 20 μL reaction with purified
MBPRep78 and/or purified GSTNPM (B23.1) or BSA in
binding buffer (10 mM Tris pH 7.5, 50 mM NaCl, 4% (v/v)
glycerol, 1 mM MgCl2, 0.44 mM EDTA, 0.5 mM ditiothreitol
(DTT), 12.5 μg polydeoxyinosinic-deoxycitidylic (Sigma) per
mL, 50 μg of BSA per mL) for 20 min at room temperature. Themixture was run on a non-denaturing 4% polyacrylamide TBE
gel and vacuum dried. The gels were exposed to BioMax MR
Film (Kodak).
Endonuclease activity assay
The hairpin probe was prepared as follows. The AAV ITRs
were excised from psub201 (Samulski et al., 1989) with XbaI
and PvuII and calf intestinal phosphatase (CIP) treated. One
picomole of the purified CIP treated fragment was incubated
with 20 U of T4 polynucleotide kinase and 50 μCi [γ-32P] ATP.
The reaction went 16 h 37 °C and purified over a 1 mL G-25
Sephadex column in TE. The labeled fragment was heated in a
boiling water bath for 5 min and then snap cooled on ice
forming the hairpin probe. The endonuclease activity assay was
performed as described previously with slight modifications (Im
and Muzyczka, 1992; Li et al., 2003). Briefly, the labeled
hairpin probe (5 fmol) was incubated with the purified
MBPRep78 (1.34 nM) and/or purified HisNPM or BSA in a
20 μL reaction containing: 25 mM HEPES·KOH pH 7.5,
10 mM NaCl, 5.5 mM MgCl2, 0.5 mM ATP, 0.2 mM DTT,
0.25% Tween 20, and 10 μg of BSA per mL. The reactions
were incubated at 37 °C for 1 h. The reaction was stopped with
20 μg of proteinase K incubated for 30 min at 37 °C. The
products were phenol/chloroform extracted and then ethanol
precipitated. The pellet was resuspended in 2 μL of 10× agarose
loading buffer and 18 μL of dH2O and run on a 10% denaturing
polyacrylamide gel containing 50% urea and vacuum dried. The
gels were exposed to BioMax MR Film (Kodak). The cleavage
product is 73 nucleotides.
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